Nurse Practitioner in Kalona, IA Accepting Medicare

3 Nurse Practitioner nurses found. Showing 1 - 3

Mrs. Ashley Nicole Greiner, ARNP Nurse Practitioner - Gerontology Medicare: Accepting Medicare Assignments Practice Location: 503 3rd St, Kalona, IA 52247 Phone: 319-656-3151    Fax: 319-656-3319

Laverta Y Eberly, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 503 3rd St, Kalona, IA 52247 Phone: 319-656-3151    Fax: 319-656-3319

Jackie K Morgan, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 503 3rd St, Kalona, IA 52247 Phone: 319-656-3151    Fax: 319-656-3319

News Archive

Attention training is a promising augment for anxiety in children who do not respond to CBT

Between 30 to 50 percent of youth in the United States diagnosed with an anxiety disorder fail to respond to cognitive-behavior therapy (CBT).

Second Sight's Argus II Retinal Prosthesis System scheduled for FDA panel review

Second Sight Medical Products Inc., the world's leading developer and manufacturer of retinal prostheses, today announced that a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel has been scheduled to review the data presented in the company's Humanitarian Device Exemption (HDE) market approval application for its Argus II Retinal Prosthesis System (Argus II prosthesis) on September 28, 2012 in Gaithersburg, Maryland.

Studies in non-human primates provide more predictive results in genetic causes of blindness

Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss, and much can be learned about the safety and effectiveness of these promising new therapies by studying them first in non-human primates before initiating clinical trials, as shown by the results of a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

New study reveals that sick teens are more isolated than other kids

A new study reveals that sick teens are more isolated than other kids, but they do not necessarily realize it and often think their friendships are stronger than they actually are.

VIVUS granted three additional patents for Qnexa

VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.

Read more Medical News

› Verified 9 days ago